Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,517.00 JPY | +2.95% |
|
+8.45% | +14.11% |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 07-02 | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,716B 53.69B 47.02B 43.31B 40.2B 76.34B 5,121B 77.37B 518B 202B 2,514B 202B 197B | P/E 2027 * |
44.9x | P/E 2028 * | 28.7x |
|---|---|---|---|---|---|
| Enterprise Value | 12,602B 77.63B 67.98B 62.62B 58.12B 110B 7,405B 112B 750B 292B 3,635B 292B 285B | EV / Sales 2027 * |
2.72x | EV / Sales 2028 * | 2.65x |
| Free-Float |
99.25% | Yield 2027 * |
3.7% | Yield 2028 * | 3.77% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +2.95% | ||
| 1 week | +8.45% | ||
| Current month | +7.02% | ||
| 1 month | +12.00% | ||
| 3 months | -4.91% | ||
| 6 months | +12.23% | ||
| Current year | +14.11% |
| 1 week | 5,112 |  | 5,517 |
| 1 month | 4,896 | | 5,517 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 24/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Free | Chief Technology Officer | 212,470 | 0.0134% | ||
| 04-27 | Free | Chief Financial Officer | 15,614 | 0.0010% | ||
| 04-27 | Free | Executive/Senior Manager | 105,416 | 0.0066% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.95% | +8.45% | +24.26% | +21.41% | 52.5B | |
| -0.56% | -1.81% | +56.26% | +160.72% | 1,082B | |
| -1.57% | +0.07% | +66.61% | +60.09% | 633B | |
| -1.76% | +0.74% | +36.54% | +86.66% | 461B | |
| -2.79% | +1.37% | +31.00% | +23.05% | 338B | |
| -2.46% | -1.38% | +37.99% | +36.52% | 299B | |
| -2.20% | -0.87% | +28.16% | +42.69% | 291B | |
| -1.77% | +1.97% | -27.22% | -40.66% | 222B | |
| -2.37% | +1.24% | +24.61% | +63.71% | 202B | |
| -1.62% | +2.18% | +15.49% | +69.32% | 163B | |
| Average | -1.47% | +4.54% | +29.37% | +52.35% | 374.49B | |
| Weighted average by Cap. | -1.58% | +5.43% | +40.78% | +79.96% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.52B 24.98B 23.01B 21.36B 40.55B 2,721B 41.1B 275B 107B 1,335B 107B 105B | 4,701B 28.96B 25.36B 23.36B 21.68B 41.17B 2,762B 41.73B 280B 109B 1,356B 109B 106B |
| Net income | 184B 1.13B 992M 914M 848M 1.61B 108B 1.63B 10.94B 4.26B 53.04B 4.25B 4.16B | 309B 1.91B 1.67B 1.54B 1.43B 2.71B 182B 2.75B 18.4B 7.16B 89.21B 7.16B 7B |
| Net Debt | 3,886B 23.93B 20.96B 19.31B 17.92B 34.03B 2,283B 34.49B 231B 89.95B 1,121B 89.89B 87.91B | 3,750B 23.1B 20.23B 18.64B 17.3B 32.85B 2,204B 33.29B 223B 86.82B 1,082B 86.76B 84.85B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | ¥5,517.00 | +2.95% | 3,686,800 |
| 03/07/26 | ¥5,359.00 | +1.61% | 4,074,200 |
| 02/07/26 | ¥5,274.00 | +2.41% | 3,538,100 |
| 01/07/26 | ¥5,150.00 | -0.10% | 4,177,200 |
| 30/06/26 | ¥5,155.00 | -0.41% | 4,329,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
